EUVIMEDEUVIMED entdecken
Crossref

Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes

Resham Lal Gurung, Huili Zheng, Jia Le Ivan Tan, Sylvia Liu, Clara Chan, Keven Ang, Clara Tan, Jian-Jun Liu iD, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim iD

Diabetes, Obesity and Metabolism · 2025-12 · 27 (12) · 7454-7463

DOI: 10.1111/dom.70153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 18.09.2025. Verfasst von Resham Lal Gurung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Medical Research Council, Alexandra Health Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Younger‐onset type 2 diabetes (YT2D) confers a disproportionately high risk of diabetic kidney disease (DKD), yet early biomarkers and underlying mechanisms remain poorly defined. We aimed to identify metabolites associated with DKD progression and integrate metabolomic and proteomic data to elucidate pathways involved in a multi‐ethnic Asian cohort. Materials and Methods In this prospective study, 787 YT2D patients (diagnosed at ≤ age 40) were followed for a median of 5.7 years. DKD progression was defined as an annual decline in estimated glomerular filtration rate (eGFR) of ≥3 mL/min/1.73 m 2 or ≥ 40% reduction in eGFR from baseline. Plasma metabolites were measured by nuclear magnetic resonance spectroscopy. Multivariable regression analysis was performed in a discovery ( N = 550) and internal validation cohort ( N = 237). Integrative metabolomic‐proteomic analysis ( N = 428) was performed using sparse partial least squares discriminant analysis (sPLS‐DA).

Results

Ninety‐eight metabolites were differentially expressed between DKD progressors and non‐progressors, of which total branched‐chain amino acids (BCAAs) (OR = 0.60, 95% CI 0.46–0.79), valine (OR = 0.62, 95% CI 0.48–0.81), and leucine (OR = 0.56, 95% CI 0.43–0.74) associated with DKD progression, independent of metabolic risk factors. Integrative analysis identified three components comprising 23 proteins and 30 metabolites, involved in the citrate cycle and apoptosis, which improved prediction of DKD progression beyond clinical risk factors (AUC 0.69–0.83).

Conclusion

Lower plasma BCAA levels are independently associated with DKD progression in YT2D. Integrative multi‐omics analysis highlights disruptions in metabolic and apoptotic pathways, providing insights into DKD pathophysiology and potential biomarkers for early risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesHumansDisease ProgressionMaleFemaleMetabolomicsAdultAge of OnsetProteomicsProspective StudiesBiomarkersAmino Acids, Branched-ChainGlomerular Filtration Rate

Stichwörter der Autor:innen

diabetes kidney diseasemetabolomicsyounger onset of type 2 diabetes

Substanzen

BiomarkersAmino Acids, Branched-Chain

Autor:innen und Institutionen

  • Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
  • Cardiovascular and Metabolic Disorders Signature Research Program, Duke-NUS Medical School, Singapore, Singapore.
  • Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

ORCID-Profile: Jian-Jun Liu, Su Chi Lim

Förderung

  • National Medical Research Council
  • Alexandra Health Systems

Zitieren

APA

Gurung, R. L., Zheng, H., Tan, J. L. I., Liu, S., Chan, C., Ang, K., Tan, C., Liu, J. J., Subramaniam, T., Sum, C. F., & Lim, S. C. (2025). Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes. Diabetes, Obesity and Metabolism, 27(12), 7454-7463. https://doi.org/10.1111/dom.70153

Vancouver

Gurung RL, Zheng H, Tan JLI, Liu S, Chan C, Ang K, et al. Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes. Diabetes, Obesity and Metabolism. 2025;27(12):7454-7463. doi:10.1111/dom.70153

BibTeX
@article{Gurung2025,
  author = {Gurung, Resham Lal and Zheng, Huili and Tan, Jia Le Ivan and Liu, Sylvia and Chan, Clara and Ang, Keven and Tan, Clara and Liu, Jian-Jun and Subramaniam, Tavintharan and Sum, Chee Fang and Lim, Su Chi},
  title = {Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {12},
  pages = {7454--7463},
  doi = {10.1111/dom.70153}
}
Kostenlos starten →